Rockwell Medical Technologies Inc

Type: Company
Name: Rockwell Medical Technologies Inc
Nationality: United States
Web Address: http://www.rockwellmed.com/
First reported 11 hours ago - Updated 8 hours ago - 2 reports

Rockwell Medical Receives $20 Mln from Hercules Technology Growth Capital

Rockwell Medical said on Tuesday that it has secured $20 million in debt financing from Hercules Technology Growth Capital . Based in Wixom, MI, Rockwell Medical is a biopharmaceutical company that targets end-stage renal disease and chronic kidney ... [Published PE Hub News - 8 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Rockwell Medical (RMTI) Closes $20M Debt Financing

Rockwell Medical (NASDAQ: RMTI) closed a $20 million debt financing with Hercules Technology Growth Capital, Inc."This $20 million straight-debt financing coupled with our recent $40 million equity financing provides us with sufficient cash to get SFP ... [Published Street Insider - 10 hours ago]
First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports
Rockwell Medical Technologies Inc
Rockwell Medical Technologies Inc

Form 4 ROCKWELL MEDICAL, INC. For: Jun 13 Filed by: BOYD RONALD D

StreetInsider.com - Form 4 ROCKWELL MEDICAL, INC. For: Jun 13 Filed by: BOYD RONALD D ... [Published Street Insider - Jun 14 2013]
First reported Jun 12 2013 - Updated Jun 12 2013 - 2 reports

Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical

Home » Blogs » On May 29th, Rockwell Medical (RMTI) announced it had completed patient dosing in its phase III CRUISE-1 efficacy and safety study of SFP-iron (Soluble Ferric Pyrophosphate-iron). The drug is delivered via dialysate (dialysis fluid) for ... [Published BioPortfolio - Jun 12 2013]
First reported Jun 10 2013 - Updated Jun 10 2013 - 1 reports

Rockwell Medical completes patient dosing in Phase III iron deficiency study

Rockwell Medical, a biopharmaceutical company targeting, has completed patient dosing in CRUISE-1 Phase III efficacy study for SFP. SFP is the company's late-stage investigational iron-delivery drug for the treatment of iron deficiency in chronic kidney ... [Published Individual.com - Jun 10 2013]
First reported Jun 03 2013 - Updated Jun 03 2013 - 1 reports

Rockwell Medical Technologies, Inc.: New Rockwell Medical Technologies, Inc. company profile published

Rockwell Medical Technologies, Inc. (Rockwell) undertakes the manufacture, sale and distribution of hemodialysis concentrate solutions and ancillary medical products. The company's products are used for performing dialysis on patients suffering from renal ... [Published TransWorldNews - Jun 03 2013]
First reported May 29 2013 - Updated May 29 2013 - 2 reports

Rockwell Medical Inc Announces SFP Phase 3 Efficacy Study CRUISE-1 Completes Patient Dosing

Rockwell Medical Inc announced that CRUISE-1 Phase 3 efficacy study for SFP has completed patient dosing. SFP is the Company's late-stage investigational iron-delivery drug for the treatment of iron deficiency in chronic kidney disease patients receiving ... [Published Reuters - May 29 2013]
First reported May 24 2013 - Updated May 24 2013 - 1 reports

Form SC 13G ROCKWELL MEDICAL, INC. Filed by: Camber Capital Management LLC

StreetInsider.com - Form SC 13G ROCKWELL MEDICAL, INC. Filed by: Camber Capital Management LLC ... [Published Street Insider - May 24 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Hot Stock: Rockwell Medical...

Rockwell Medical Technologies (NASDAQ:RMTI) is one of today's best performing low-priced stocks, up 5.4% to $3.71 on 1.2x average daily volume. Rockwell Medical Technologies has traded 600,000 shares thus far today, vs. average volume of 488,000 shares ... [Published Financial News Network online - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 1 reports

Hot Stock: Rockwell Medical Technologies, Shares Gain 5.4% (RMTI)

(Financial News Network On) Rockwell Medical Technologies (NASDAQ:RMTI) is one of today's best performing low-priced stocks, up 5.4% to $3.71 on 1.2x average daily volume. Rockwell Medical Technologies has traded 600,000 shares thus far today, vs. average ... [Published Individual.com - May 21 2013]
First reported May 21 2013 - Updated May 21 2013 - 2 reports

Rockwell Medical Inc concludes USD40.3m public offering

Biopharmaceutical company Rockwell Medical Inc (NASDAQ:RMTI) revealed on Monday the completion of the sale of 13,196,721 common shares in an underwritten public offering. This public offering included 1,721,311 shares of its common stock to cover over ... [Published Individual.com - May 21 2013]
First reported May 20 2013 - Updated May 20 2013 - 3 reports

Rockwell Medical Inc Closes $40.3 Million Public Offering Of Common Stock

Rockwell Medical Inc announced that the closing of the sale of 13,196,721 common shares, including 1,721,311 shares of common to cover overallotments, at $3.05 per share in an underwritten public offering for an aggregate offering amount of approximately ... [Published Reuters - May 20 2013]

Quotes

...financing provides us with sufficient cash to get SFP to commercial launch," stated Rob Chioini, Founder, Chairman and CEO of Rockwell Medical. "We are on schedule to release Phase 3 efficacy data for CRUISE-1 and look forward to those study results."
Rockwell Medical (RMTI) Closes $20M Debt Financing [Published Street Insider - 10 hours ago]
More From BioPortfolio on "Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical"
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical [Published BioPortfolio - Jun 12 2013]
...Rockwell Chief Medical Officer, Dr. Raymond Pratt, expressed his hope in the phase IIIIII CRUISE trial results in the PRIME press release noting "In this study, a 37% higher ESA dose was needed in the placebo arm to maintain hemoglobin compared to the SFP arm, but in the Phase III CRUISE efficacy studies the ESA dose is kept constant, unable to be titrated, over the 12-month study period. The PRIME results support our belief that SFP will demonstrate efficacy in the Phase III CRUISE clinical studies by maintaining hemoglobin in the SFP arm while hemoglobin decreases in the placebo arm." If Dr. Pratt's opinion holds to be true, investors may perceive the upcoming CRUISE-1 data very favorably, although the CRUISE-2 trial would still need...
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical [Published Seeking Alpha - Jun 12 2013]
...for Rockwell, and we are excited to be so close to top-line results," stated Robert L Chioini, Founder, Chairman and CEO of Rockwell Medical. "Our clinical team continues to perform at a high level, and we thank them, the study investigators and certainly the patients for their outstanding effort and participation. We look forward to the upcoming CRUISE-1 study results."
Rockwell Medical completes patient dosing in Phase III iron deficiency study [Published Individual.com - Jun 10 2013]

More Content

All (71) | News (36) | Reports (5) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (18)
sort by: Date | Relevance
Iron Deficiency Anemia - Pipeline Review, H1 2013 [Published Individual.com - 7 hours ago]
Rockwell Medical Receives $20 Mln from Hercules... [Published PE Hub News - 8 hours ago]
Rockwell Medical (RMTI) Closes $20M Debt Financing [Published Street Insider - 10 hours ago]
Rockwell Medical Receives $20 Million in New Fi... [Published Individual.com - 11 hours ago]
Rockwell Medical Receives $20 Million in New Fi... [Published Marketwire - Breaking News Releases - 11 hours ago]
Form 4 ROCKWELL MEDICAL, INC. For: Jun 13 Filed... [Published Street Insider - Jun 14 2013]
Multiple Pending Catalysts Should Keep Investor... [Published BioPortfolio - Jun 12 2013]
Multiple Pending Catalysts Should Keep Investor... [Published Seeking Alpha - Jun 12 2013]
Rockwell Medical completes patient dosing in Ph... [Published Individual.com - Jun 10 2013]
Rockwell Medical announces encouraging results ... [Published Individual.com - Jun 04 2013]
Rockwell Medical Technologies, Inc.: New Rockwe... [Published TransWorldNews - Jun 03 2013]
4 Biotech Stocks Offering Potential, Pipeline A... [Published Seeking Alpha - May 29 2013]
Rockwell Medical Inc Announces SFP Phase 3 Effi... [Published Reuters - May 29 2013]
Rockwell Medical Announces SFP Phase 3 Efficacy... [Published Benzinga.com - May 29 2013]
Rockwell Medical Announces SFP Phase 3 Efficacy... [Published Marketwire - Breaking News Releases - May 29 2013]
Form SC 13G ROCKWELL MEDICAL, INC. Filed by: Ca... [Published Street Insider - May 24 2013]
Rockwell Steadies Itself For A Phase III Run-Up [Published BioPortfolio - May 23 2013]
Rockwell Steadies Itself For A Phase III Run-Up [Published Seeking Alpha - May 22 2013]
Rockwell Medical Q1 net loss increases [Published Individual.com - May 22 2013]
Rockwell Medical Run-Up Trade Follows Financing [Published BioPortfolio - May 21 2013]
Hot Stock: Rockwell Medical... [Published Financial News Network online - May 21 2013]
Hot Stock: Rockwell Medical Technologies, Share... [Published Individual.com - May 21 2013]
Rockwell Medical Inc concludes USD40.3m public ... [Published Individual.com - May 21 2013]
Rockwell Medical announces closing of USD40.3m ... [Published Individual.com - May 21 2013]
Top After-Market NASDAQ Movers (China Sunergy, ... [Published International Business Times UK - May 21 2013]
Given Imaging Announces New Data On SmartPill(R... [Published BioMedReports - May 21 2013]
Rockwell Medical Inc Closes $40.3 Million Publi... [Published Reuters - May 20 2013]
Rockwell Medical Closes $40.3 Million Public Of... [Published Investors Business Daily - May 20 2013]
Rockwell Medical Closes $40.3 Million Public Of... [Published Marketwire - Breaking News Releases - May 20 2013]
Rockwell Medical Inc Announces PRIME Study Resu... [Published Reuters - May 20 2013]
1 2 3
In Focus
  •  
Jake Zamansky, Jeff Briggs, Dan Bailey, [more]
  •  
DaVita HealthCare Partners Inc, NxStage Medical Inc, Herbalife Ltd, [more]
  •  
European Space Agency, FDA Food & Drug Administration, US Securities and Exchange Commission, [more]
  •  
8-k, Iron, Common Shares, [more]
  •  
S&P 500, iPad, iPhone, [more]
  •  
Wixom (United States), Hercules (United States), Suzhou (Jiangsu, China), [more]
  •  
United States, Turkey, China, [more]
  •  
Diseases, Narcotics, Medication, [more]
  •  
IT, Banking & Financial Services, Health, [more]
Marketwire - Breaking News Releases, SEC Filings, Individual.com, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Financings of the Fortnight Waits For Public In... [Published The IN VIVO Blog - May 17 2013]
It’s been another IPO-intensive couple of weeks here at FOTF HQ. We keep looking for other things to write about, but sometimes the fastest shave on deadline is with Occam’s razor. Or something like that. We didn't exactly ace our philosophy classes ...
ACADIA Prices Public Offering and 2 Other Hot S... [Published Wall St. Cheat Sheet - May 15 2013]
ACADIA Pharmaceuticals ( NASDAQ:ACAD ): Current price $13.28 On Wednesday, the firm reported the pricing of an underwritten public offering of 8 million shares of its common stock, at a price to the public of $12.50 per share. It is anticipated that ...
4 Healthcare Stock Stories For Tuesday Investme... [Published Wall St. Cheat Sheet - May 15 2013]
Cleveland BioLabs ( NASDAQ:CBLI ): Closing price $1.58 Cleveland BioLabs and Incuron, a joint venture between the former and Bioprocess Capital Ventures, on Tuesday reported the receipt of a Notice of Allowance from the United States Patent and Trademark ...
Rockwell submits injectable active vitamin D dr... [Published PBR - News - Apr 04 2013]
Rockwell Medical has submitted the manufacturing data of Calcitriol, an injectable active vitamin D drug formulation, to FDA for approval. ...
Financings Of the Fortnight Sees Drug Companies... [Published The IN VIVO Blog - Mar 22 2013]
When the Nasdaq’s biotech index topped 1,600 late last week, many people noted it was an all-time high, even higher than the 2000 bubble. (Not adjusting for inflation, however.) It has stayed above 1,600 all week, and no surprise, the money-chasers ...
1 2 3

Press Releases

sort by: Date | Relevance
Rockwell Medical Receives $20 Million in New Fi... [Published Marketwire - Breaking News Releases - 11 hours ago]
Rockwell Medical Announces SFP Phase 3 Efficacy... [Published Marketwire - Breaking News Releases - May 29 2013]
Rockwell Medical Closes $40.3 Million Public Of... [Published Marketwire - Breaking News Releases - May 20 2013]
Rockwell Medical Presents PRIME Study Results a... [Published Marketwire - Breaking News Releases - May 20 2013]
Rockwell Medical Announces the Exercise of Over... [Published Marketwire - Breaking News Releases - May 16 2013]
1 2 3 4
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.